<DOC>
	<DOCNO>NCT00986180</DOCNO>
	<brief_summary>Evaluate NUCYNTA ( tapentadol ) immediate release ( IR ) compare oxycodone IR treatment acute low back pain .</brief_summary>
	<brief_title>NUCYNTA ( Tapentadol Immediate Release ) Versus Oxycodone Immediate Release Treatment Acute Low Back Pain</brief_title>
	<detailed_description>This randomize , outpatient , multicenter , double-blind study ( blind patient study doctor ) compare NUCYNTA oxycodone IR treatment patient acute ( new onset ) low back pain also associate leg pain radiates ( travel ) knee . Patients screen study eligibility Visit 1 . The study explain informed consent obtain . Potential patient must satisfy eligibility criterion enrol study . Eligible candidate proceed Double-Blind Treatment Phase . At time study entry , prohibit medication discontinue disallow throughout study . All patient call interactive voice response system ( IVRS ) complete pain assessment twice daily throughout study . Patients discontinue early reason instruct contact study site complete final assessment , prior take supplemental pain medication applicable , schedule final study visit . All patient return study site Day 5 ( Visit 2 ) evaluate study personnel , appropriate , continue study treatment additional 5 day . Patients return study site final visit Day 10/End Study ( Visit 3 ) final study assessment . The treatment duration 10 day . The sponsor collect adverse event start signing informed consent form . Adverse event report subject duration study . Any clinically significant abnormality persist end study follow investigator resolution clinically stable endpoint reach . Blood sample serum chemistry hematology urine sample urinalysis collect . The investigator review laboratory report , document review , record clinically relevant change occur study . The following test perform central laboratory : Urine Pregnancy Testing woman childbearing potential , Urine Drug Screen , Vital Signs ( pulse rate blood pressure ) , Physical Examination , Neurological Examination , Vomiting Assessment . The study conduct approximately 80 site United States ( US ) . Patients randomize one two follow treatment group : NUCYNTA 50 , 75 100 mg every 4 6 hour 10 day need pain . Oxycodone IR 5 , 10 15 mg every 4 6 hour need pain . Patients begin treatment Day 1 one `` low dose '' capsule study drug ( NUCYNTA 50 mg oxycodone IR 5 mg ) . Subsequent dose adjustment make study patient , need , achieve dose provide meaningful improvement pain intensity</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>At Visit 1 ( study entry ) patient must medical history physical neurological examination support clinical diagnosis acute low back pain felt low leg knee onset longer 30 day Visit 1 At Visit 1 patient must report qualify pain intensity score Patients must appropriate candidate treatment oral opioid pain medication investigator 's clinical judgment Patients must able appropriately verbalize pain characteristic complete protocol require measurements/assessments without assistance Patients must medically stable basis physical examination , medical history , vital sign , clinical laboratory test perform screen History back ( cervical , thoracic lumbosacral ) pain =50 % time 1 year prior first visit History low back pain episode , exception current acute low back pain episode , within 3 month prior first visit great mild pain intensity , associate disability ( e.g. , loss time work , family , activity daily live ) , necessitate use opioid ( narcotic ) analgesic include tramadol Medical history physical examination result suggest acute low back pain neurological symptom sign cause serious medical condition ( e.g. , fever , chill , unexplained weight loss , bowel urinary bladder dysfunction incontinence , bilateral leg weakness , progressive weakness , paralysis ) There high probability surgical intervention back pain projected time study increase severity leg pain deficit Had either surgical procedure involve spine intervertebral disc lower back region within 1 year prior Visit 1 &gt; 1 surgical procedure ( ) involve spine intervertebral disc lower back region painful condition could interfere study assessment patient 's ability differentiate pain associate acute low back pain episode pain associate another condition History severe lumbar spinal stenosis , fibromyalgia , ankylose spondylitis history epilepsy recurrent seizures Unable unwilling discontinue prohibit medication time randomization time participation study Known suspect history alcohol drug abuse base medical history , physical examination , urine drug screening , investigator 's clinical judgment History cancer malignancy within 2 year prior first visit , exception basal cell skin carcinoma Have file plan file worker 's compensation claim issue relate current acute low back pain episode Currently involve litigation plan seek legal recourse issue relate acute low back pain Known allergy , hypersensitivity , intolerance tapentadol comparator ( oxycodone ) excipients use manufacture Had previously enrol tapentadol clinical study pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Acute Low Back Pain</keyword>
	<keyword>Low Back Pain With Leg Pain Below The Knee</keyword>
	<keyword>Radiculopathy , Oxycodone</keyword>
	<keyword>Tapentadol</keyword>
	<keyword>NUCYNTA</keyword>
</DOC>